6.
Brisse H, McCarville M, Granata C, Krug K, Wootton-Gorges S, Kanegawa K
. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology. 2011; 261(1):243-57.
DOI: 10.1148/radiol.11101352.
View
7.
Ito A, Uno T, Gunji Y, Yamauchi T, Egami S, Kawarasaki H
. Obstructive jaundice as a presentation of ganglioneuroblastoma. J Pediatr Hematol Oncol. 2005; 27(2):112-4.
DOI: 10.1097/01.mph.0000153445.20945.fd.
View
8.
Wildhaber B, Niggli F, Bergstrasser E, Stallmach T, Sacher P
. Paraneoplastic syndromes in ganglioneuroblastoma: contrasting symptoms of constipation and diarrhoea. Eur J Pediatr. 2003; 162(7-8):511-513.
DOI: 10.1007/s00431-003-1212-0.
View
9.
Wei Z, Li J, Jin Y, Liu Y, Wang P, Cao Y
. The application and value of radiotherapy at the primary site in patients with high-risk neuroblastoma. Br J Radiol. 2022; 95(1134):20211086.
PMC: 10996409.
DOI: 10.1259/bjr.20211086.
View
10.
Wakabayashi H, Kayano D, Inaki A, Araki R, Kuroda R, Akatani N
. Diagnostic Use of Post-therapy I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma. Diagnostics (Basel). 2020; 10(9).
PMC: 7555271.
DOI: 10.3390/diagnostics10090663.
View
11.
Zeiter D
. Abdominal Pain in Children: From the Eternal City to the Examination Room. Pediatr Clin North Am. 2017; 64(3):525-541.
DOI: 10.1016/j.pcl.2017.01.012.
View
12.
Di Lorenzo C, Colletti R, Lehmann H, Boyle J, Gerson W, Hyams J
. Chronic abdominal pain in children: a clinical report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2005; 40(3):245-8.
DOI: 10.1097/01.mpg.0000155367.44628.21.
View
13.
Czkwianianc E, Zalewska-Szewczyk B, Kobos J, Socha-Banasiak A, Janczar S, Prymus-Kasinska S
. Uncommon reasons of the digestive tract-related paraneoplastic syndromes in children with neuroblastic tumors: three case reports. Contemp Oncol (Pozn). 2018; 22(1):42-46.
PMC: 5910524.
DOI: 10.5114/wo.2018.74393.
View
14.
Ladenstein R, Lambert B, Potschger U, Castellani M, Lewington V, Bar-Sever Z
. Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials. Eur J Nucl Med Mol Imaging. 2017; 45(2):292-305.
PMC: 5747549.
DOI: 10.1007/s00259-017-3829-7.
View
15.
Mojtahed H, Rose E, Feddersen R
. Ganglioneuroblastoma masquerading as chronic vomiting. Clin Pediatr (Phila). 1995; 34(2):110-3.
DOI: 10.1177/000992289503400209.
View
16.
Choi J, Ro J
. Mediastinal neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: Pathology review and diagnostic approach. Semin Diagn Pathol. 2021; 39(2):120-130.
DOI: 10.1053/j.semdp.2021.06.007.
View
17.
Monclair T, Brodeur G, Ambros P, Brisse H, Cecchetto G, Holmes K
. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol. 2008; 27(2):298-303.
PMC: 2650389.
DOI: 10.1200/JCO.2008.16.6876.
View
18.
Li Q, Wang J, Cheng Y, Hu A, Li D, Wang X
. Long-Term Survival of Neuroblastoma Patients Receiving Surgery, Chemotherapy, and Radiotherapy: A Propensity Score Matching Study. J Clin Med. 2023; 12(3).
PMC: 9918249.
DOI: 10.3390/jcm12030754.
View
19.
Okonta V, Majlessipour F, Baca N
. Ganglioneuroblastoma in a Child With Neurofibromatosis Type 1: A Case Report and Literature Review. J Pediatr Hematol Oncol. 2022; 45(1):e131-e134.
DOI: 10.1097/MPH.0000000000002461.
View
20.
Whitlock R, Mehl S, Larson S, Foster J, Hicks J, Nuchtern J
. Characteristics of benign neuroblastic tumors: Is surgery always necessary?. J Pediatr Surg. 2021; 57(8):1538-1543.
DOI: 10.1016/j.jpedsurg.2021.07.002.
View